1. Home
  2. BCH vs BNTX Comparison

BCH vs BNTX Comparison

Compare BCH & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco De Chile ADS

BCH

Banco De Chile ADS

HOLD

Current Price

$41.53

Market Cap

20.3B

Sector

Finance

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$100.51

Market Cap

24.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCH
BNTX
Founded
1893
2008
Country
Chile
Germany
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3B
24.2B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
BCH
BNTX
Price
$41.53
$100.51
Analyst Decision
Hold
Strong Buy
Analyst Count
1
13
Target Price
$36.00
$133.46
AVG Volume (30 Days)
265.8K
1.6M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
4.52%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.84
N/A
Revenue Next Year
$6.49
$3.37
P/E Ratio
$16.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.95
$79.81
52 Week High
$46.77
$124.00

Technical Indicators

Market Signals
Indicator
BCH
BNTX
Relative Strength Index (RSI) 48.70 50.50
Support Level $39.34 $87.58
Resistance Level $41.63 $104.05
Average True Range (ATR) 0.84 3.95
MACD -0.10 -0.44
Stochastic Oscillator 41.86 35.73

Price Performance

Historical Comparison
BCH
BNTX

About BCH Banco De Chile ADS

Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: